HUP0201863A2 - Új morfolinszármazékok, eljárás előállításukra és azokat tartalmazó gyógyszerkészítmények - Google Patents
Új morfolinszármazékok, eljárás előállításukra és azokat tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0201863A2 HUP0201863A2 HU0201863A HUP0201863A HUP0201863A2 HU P0201863 A2 HUP0201863 A2 HU P0201863A2 HU 0201863 A HU0201863 A HU 0201863A HU P0201863 A HUP0201863 A HU P0201863A HU P0201863 A2 HUP0201863 A2 HU P0201863A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- production
- alkyl
- same
- pharmaceutical preparations
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title 1
- 150000002780 morpholines Chemical class 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 2
- QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- 101000600903 Homo sapiens Substance-P receptor Proteins 0.000 abstract 1
- 102100024304 Protachykinin-1 Human genes 0.000 abstract 1
- 101800003906 Substance P Proteins 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
A találmány az (I) általános képletű vegyületekre, ásványi vagyszerves savakkal képzett sóikra, szolvátjaikra és/vagy hidrátjairavonatkozik, melyek erős affinitást és nagyfokú szelektivitást mutatnaka P-anyag humán NKl receptorai iránt. A találmány a fenti származékokelállítására az előállítás során használt intermedierekre a fentivegyületeket tartalmazó gyógyszerösszetételekre és mindazon kórképekkezelésére alkalmas gyógyszerek előállítására való használatukravonatkoznak. Az (I) képletű vegyület, amelyben: Ar jelentésehalogénnel, vagy (C1-C3)alkil csoporttal mono- vagy diszubsztituáltfenilcsoport; X jelentése csoport; R1 jelentése klóratom, brómatom,(Cl-C3)alkilcsoport vagy trifluor-metilcsoport; R2 jelentése (C1-C6)alkil; (C3-C6) cikloalkilcsoport; vagy -CR4R5CONR6R7 csoport R3jelentése -CR4R5CONR6R7 csoport; R4 és R5 ugyanazon csoportot jelenti,amely lehet metil, etil, n-propil vagy n-butil; vagy pedig az R4 ésR5, valamint a szénatom, amelyhez kapcsolódnak, együtt alkot egy (C3-C6)cikloalkilcsoportot; R6 és R7 egymástól függetlenül jelenthetnekhidrogénatomot; (C1-C3) alkil csoportot. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9903854A FR2791346B3 (fr) | 1999-03-25 | 1999-03-25 | Nouveaux derives de morpholine, procede pour leur preparation et compositions pharmaceutiques les contenant |
| PCT/FR2000/000695 WO2000058292A1 (fr) | 1999-03-25 | 2000-03-21 | Nouveaux derives de morpholine, procede pour leur preparation et compositions pharmaceutiques les contenant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0201863A2 true HUP0201863A2 (hu) | 2002-12-28 |
| HUP0201863A3 HUP0201863A3 (en) | 2003-03-28 |
Family
ID=9543720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0201863A HUP0201863A3 (en) | 1999-03-25 | 2000-03-21 | Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing the same |
Country Status (41)
| Country | Link |
|---|---|
| US (1) | US6506750B1 (hu) |
| EP (1) | EP1165528B1 (hu) |
| JP (1) | JP3853155B2 (hu) |
| KR (1) | KR100696340B1 (hu) |
| CN (1) | CN100422160C (hu) |
| AR (1) | AR023139A1 (hu) |
| AT (1) | ATE275136T1 (hu) |
| AU (1) | AU756855B2 (hu) |
| BG (1) | BG64623B1 (hu) |
| BR (1) | BR0009281B1 (hu) |
| CA (1) | CA2366829C (hu) |
| CO (1) | CO5160340A1 (hu) |
| CZ (1) | CZ300911B6 (hu) |
| DE (1) | DE60013418T2 (hu) |
| DK (1) | DK1165528T3 (hu) |
| EE (1) | EE04525B1 (hu) |
| ES (1) | ES2226794T3 (hu) |
| FR (1) | FR2791346B3 (hu) |
| HK (1) | HK1042092B (hu) |
| HR (1) | HRP20010704B1 (hu) |
| HU (1) | HUP0201863A3 (hu) |
| ID (1) | ID29871A (hu) |
| IL (2) | IL145041A0 (hu) |
| IS (1) | IS2338B (hu) |
| ME (2) | ME00057B (hu) |
| MX (1) | MXPA01009643A (hu) |
| NO (1) | NO321576B1 (hu) |
| NZ (1) | NZ513674A (hu) |
| PE (1) | PE20001596A1 (hu) |
| PL (1) | PL205318B1 (hu) |
| PT (1) | PT1165528E (hu) |
| RS (1) | RS50085B (hu) |
| RU (1) | RU2222537C2 (hu) |
| SI (1) | SI1165528T1 (hu) |
| SK (1) | SK286977B6 (hu) |
| TR (1) | TR200102639T2 (hu) |
| TW (1) | TW534906B (hu) |
| UA (1) | UA73931C2 (hu) |
| UY (1) | UY26079A1 (hu) |
| WO (1) | WO2000058292A1 (hu) |
| ZA (1) | ZA200106981B (hu) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6943160B2 (en) * | 2000-11-28 | 2005-09-13 | Smithkline Beecham Plc | Morpholine derivatives as antagonists of orexin receptors |
| FR2824828B1 (fr) * | 2001-05-21 | 2005-05-20 | Sanofi Synthelabo | Nouveaux derives de piperidinecarboxamide, un procede pour leur preparation et les compositions pharmaceutiques les contenant |
| GB0228787D0 (en) * | 2002-12-10 | 2003-01-15 | Pfizer Ltd | Morpholine dopamine agonists |
| JP2006511555A (ja) * | 2002-12-13 | 2006-04-06 | スミスクライン ビーチャム コーポレーション | Ｃｃｒ５拮抗剤としての複素環式化合物 |
| JO2485B1 (en) * | 2002-12-23 | 2009-01-20 | شركة جانسين فارماسوتيكا ان. في | 1-Piperidine-3-Yl-4-Piperidine-4-Yl-Piperazine derivatives substituted and used as quinine antagonists |
| JP2007515425A (ja) * | 2003-12-22 | 2007-06-14 | シェーリング コーポレイション | 医薬組成物 |
| FR2873373B1 (fr) * | 2004-07-23 | 2006-09-08 | Sanofi Synthelabo | Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique |
| CN103142569B (zh) * | 2013-02-27 | 2016-01-20 | 南京医科大学 | 2,6-二异丙基苯甲酸及其衍生物作为神经保护剂的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ3134U1 (cs) * | 1995-01-10 | 1995-03-17 | Pavel Ing. Janda | Rotor universálního radiálního ventilátoru |
| FR2729954B1 (fr) | 1995-01-30 | 1997-08-01 | Sanofi Sa | Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant |
| US5780466A (en) * | 1995-01-30 | 1998-07-14 | Sanofi | Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present |
| HU224225B1 (hu) * | 1995-12-01 | 2005-06-28 | Sankyo Co. Ltd. | Tachikinin receptor antagonista hatású heterociklusos vegyületek, ezek előállítási eljárása és alkalmazásuk gyógyszerkészítmények előállítására |
| JP3192631B2 (ja) * | 1997-05-28 | 2001-07-30 | 三共株式会社 | 飽和複素環化合物からなる医薬 |
| EP1048658B1 (en) | 1997-12-04 | 2005-06-15 | Sankyo Company Limited | Alicyclic acylated heterocyclic derivatives |
-
1999
- 1999-03-25 FR FR9903854A patent/FR2791346B3/fr not_active Expired - Lifetime
-
2000
- 2000-03-21 TR TR2001/02639T patent/TR200102639T2/xx unknown
- 2000-03-21 RU RU2001124835/04A patent/RU2222537C2/ru not_active IP Right Cessation
- 2000-03-21 PL PL351317A patent/PL205318B1/pl not_active IP Right Cessation
- 2000-03-21 SK SK1346-2001A patent/SK286977B6/sk not_active IP Right Cessation
- 2000-03-21 MX MXPA01009643A patent/MXPA01009643A/es unknown
- 2000-03-21 EE EEP200100499A patent/EE04525B1/xx not_active IP Right Cessation
- 2000-03-21 CA CA002366829A patent/CA2366829C/fr not_active Expired - Lifetime
- 2000-03-21 JP JP2000607995A patent/JP3853155B2/ja not_active Expired - Fee Related
- 2000-03-21 DE DE60013418T patent/DE60013418T2/de not_active Expired - Lifetime
- 2000-03-21 EP EP00911009A patent/EP1165528B1/fr not_active Expired - Lifetime
- 2000-03-21 NZ NZ513674A patent/NZ513674A/en not_active IP Right Cessation
- 2000-03-21 AU AU33016/00A patent/AU756855B2/en not_active Ceased
- 2000-03-21 IL IL14504100A patent/IL145041A0/xx unknown
- 2000-03-21 AT AT00911009T patent/ATE275136T1/de active
- 2000-03-21 RS YUP-682/01A patent/RS50085B/sr unknown
- 2000-03-21 ID IDW00200101969A patent/ID29871A/id unknown
- 2000-03-21 ME MEP-2008-120A patent/ME00057B/me unknown
- 2000-03-21 DK DK00911009T patent/DK1165528T3/da active
- 2000-03-21 KR KR1020017012121A patent/KR100696340B1/ko not_active IP Right Cessation
- 2000-03-21 ME MEP-120/08A patent/MEP12008A/xx unknown
- 2000-03-21 ES ES00911009T patent/ES2226794T3/es not_active Expired - Lifetime
- 2000-03-21 WO PCT/FR2000/000695 patent/WO2000058292A1/fr active IP Right Grant
- 2000-03-21 CZ CZ20013365A patent/CZ300911B6/cs not_active IP Right Cessation
- 2000-03-21 PT PT00911009T patent/PT1165528E/pt unknown
- 2000-03-21 CN CNB008055084A patent/CN100422160C/zh not_active Expired - Fee Related
- 2000-03-21 SI SI200030536T patent/SI1165528T1/xx unknown
- 2000-03-21 BR BRPI0009281-9A patent/BR0009281B1/pt not_active IP Right Cessation
- 2000-03-21 US US09/937,279 patent/US6506750B1/en not_active Expired - Lifetime
- 2000-03-21 HU HU0201863A patent/HUP0201863A3/hu unknown
- 2000-03-21 UA UA2001096121A patent/UA73931C2/uk unknown
- 2000-03-23 AR ARP000101299A patent/AR023139A1/es active IP Right Grant
- 2000-03-24 TW TW089105498A patent/TW534906B/zh not_active IP Right Cessation
- 2000-03-24 CO CO00021353A patent/CO5160340A1/es unknown
- 2000-03-27 UY UY26079A patent/UY26079A1/es not_active IP Right Cessation
- 2000-03-27 PE PE2000000258A patent/PE20001596A1/es not_active Application Discontinuation
-
2001
- 2001-08-21 IL IL145041A patent/IL145041A/en not_active IP Right Cessation
- 2001-08-23 ZA ZA200106981A patent/ZA200106981B/en unknown
- 2001-08-24 IS IS6063A patent/IS2338B/is unknown
- 2001-09-19 BG BG105923A patent/BG64623B1/bg unknown
- 2001-09-24 NO NO20014632A patent/NO321576B1/no not_active IP Right Cessation
- 2001-09-25 HR HR20010704A patent/HRP20010704B1/xx not_active IP Right Cessation
-
2002
- 2002-05-27 HK HK02103933.2A patent/HK1042092B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20042584L (no) | Dibenzylaminforbindelser og farmasoytisk anvendelse derav | |
| HUP0002347A2 (hu) | Hidantoin-, oxazol- és pirrolszármazékok alkalmazása gyulladásos betegségek kezelésére alkalmazható gyógyszerkészítmények előállítására | |
| HUT41770A (en) | Process for producing indol derivatives containing heterocyclic substituents and pharmaceutical compositions containing them | |
| HUP0401649A2 (hu) | Benzoxazin-, benzotiazinszármazékok és gyógyszerkészítményeik | |
| HUP0402376A2 (hu) | Imidazol-4-karboxamid-származékok, előállításuk és az ezeket tartalmazó, elhízás kezelésére alkalmas gyógyszerkészítmények | |
| HUP0200248A2 (hu) | Pajzsmirigy-receptor ligandumként alkalmazható oxámsavszármazékok, azokat hatóanyagként tartalmazó gyógyszerkészítmények, valamint alkalmazásuk | |
| HUP9902471A2 (hu) | Piperazin- és piperidinvegyületek, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények | |
| HUP0300920A1 (hu) | Szubsztituált benzidszármazékok és gyógyszerként történő felhasználásuk | |
| PE20040155A1 (es) | Derivados aminoinazoles, procedimiento de preparacion e intermedios de este procedimiento a titulo de medicamentos y composiciones farmaceuticas que los contienen | |
| HUP0100051A2 (hu) | Antimikrobiális kinolonok, ezeket tartalmazó készítmények és alkalmazásuk | |
| SE9702799D0 (sv) | New compounds | |
| DE3876813D1 (de) | 3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a. | |
| HUP0303568A2 (hu) | Benzotiofénszármazékok, eljárás előállításukra és alkalmazásuk | |
| HUP0500201A2 (hu) | Policiklusos vegyületek, mint potenciális alfa2-adrenoceptor antagonisták és ezeket tartalmazó gyógyszerkészítmények | |
| ATE482933T1 (de) | Sulfopyrrolderivate | |
| HUP0201863A2 (hu) | Új morfolinszármazékok, eljárás előállításukra és azokat tartalmazó gyógyszerkészítmények | |
| HUP0203787A2 (hu) | Hidroxi-acetil-piperazinnal szubsztituált oxazolidinon-benzoesav-észterek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| BG103207A (en) | Esters of the arylcycloalkanecarboxylic acids, their application, pharmaceutical compositions and their preparation | |
| HUP0203187A2 (hu) | Izoxazolszármazékok mint foszfodiészteráz VII inhibitorok és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0303361A2 (hu) | Helyettesített 1-amino-bután-3-ol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| NZ519126A (en) | Novel IL-8 receptor antagonists | |
| HUP0003455A2 (hu) | Benzoxazin- és benzotiazinszármazékok és gyógyszerekben történő alkalmazásuk | |
| RS50210B (sr) | Derivati (1-fenaci-3-fenil-3-piperidiletil) piperidina, postupak za njihovo dobijanje i farmaceutske kompozicije koje ih sadrže | |
| EA200101109A1 (ru) | Производные 1-трифторметил-4-гидрокси-7-пиперидинил-аминометилхромана | |
| EA200400469A1 (ru) | Замещенные производные алкиламинопиридазинона, способ их получения и содержащие их фармацевтические композиции |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |